pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

697 catalysts · 3,085 8k filing · 576 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage · 121 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 56 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: earnings×type: approval×from 2026-04-08×clear all
type
  • 8k filing3,085
  • earnings576
  • phase 2 completion172
  • grant169
  • drug shortage133
  • approval121
phase 1 completion
73
  • phase 2 initiation62
  • device 510k54
  • recall51
  • therapy area

    no tagged catalysts yet

    Week of Apr 6, 2026

    45
    ›Apr 8, 2026approval126d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Apr 8, 2026approval126d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 8, 2026approval126d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Apr 8, 2026approval126d agoINGREZZA SPRINKLE (VALBENAZINE TOSYLATE) — FDA approvalVALBENAZINE TOSYLATE

    Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL

    full page →VALBENAZINE TOSYLATE →fda approvals ↗
    ›Apr 8, 2026approval126d agoHALOPERIDOL — FDA approvalHALOPERIDOL

    Sponsor: AIPING PHARM INC. Form: TABLET. Route: ORAL

    full page →HALOPERIDOL →fda approvals ↗
    ›Apr 8, 2026approval126d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

    Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 8, 2026approval126d agoOFLOXACIN — FDA approvalOFLOXACIN

    Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →OFLOXACIN →fda approvals ↗
    ›Apr 8, 2026approval126d agoPROGESTERONE — FDA approvalPROGESTERONE

    Sponsor: GLENMARK PHARMS LTD. Form: INSERT. Route: VAGINAL

    full page →PROGESTERONE →fda approvals ↗
    ›Apr 8, 2026approval126d agoELTROMBOPAG OLAMINE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: ZENARA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

    Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

    full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗
    ›Apr 9, 2026approval125d agoVABYSMO (FARICIMAB-SVOA) — FDA approvalfaricimab

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL

    full page →faricimab →fda approvals ↗
    ›Apr 9, 2026approval125d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

    Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL

    full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗
    ›Apr 9, 2026approval125d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: UPSHER SMITH LABS. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →duloxetine hydrochloride DR →fda approvals ↗
    ›Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 9, 2026approval125d agoMESNA — FDA approvalMESNA

    Sponsor: RISING. Form: INJECTABLE. Route: INTRAVENOUS

    full page →MESNA →fda approvals ↗
    ›Apr 9, 2026approval125d agoONUREG (AZACITIDINE) — FDA approvalBristol-Myers Squibb Co

    Sponsor: BRISTOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

    Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoCOSOPT PF (DORZOLAMIDE HYDROCHLORIDE) — FDA approvalCosopt

    Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Cosopt →fda approvals ↗
    ›Apr 9, 2026approval125d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

    Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval125d agoREZENOPY (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

    Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL

    full page →naloxone hydrochloride →fda approvals ↗
    ›Apr 9, 2026approval125d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

    Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

    full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval125d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 10, 2026approval124d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 10, 2026approval124d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →LOSARTAN POTASSIUM →fda approvals ↗
    ›Apr 10, 2026approval124d agoMETHYLPREDNISOLONE — FDA approvalPFIZER INC

    Sponsor: TIANJIN TIANYAO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 10, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 10, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 10, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 10, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 10, 2026approval124d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
    ›Apr 10, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 10, 2026approval124d agoLIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE) — FDA approvalLaryng-O-Jet

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →Laryng-O-Jet →fda approvals ↗
    ›Apr 10, 2026approval124d agoDILTIAZEM HYDROCHLORIDE — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 10, 2026approval124d agoMETHYLPREDNISOLONE — FDA approvalMEDROL

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →MEDROL →fda approvals ↗
    ›Apr 10, 2026approval124d agoMYCOPHENOLATE MOFETIL — FDA approvalMYCOPHENOLATE MOFETIL

    Sponsor: STRIDES PHARMA INTL. Form: FOR SUSPENSION. Route: ORAL

    full page →MYCOPHENOLATE MOFETIL →fda approvals ↗

    Week of Apr 13, 2026

    5
    ›Apr 13, 2026approval121d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Apr 13, 2026approval
    ← prev
    page 1 of 14
    next →
    121d ago
    VANFLYTA (QUIZARTINIB DIHYDROCHLORIDE) — FDA approvalquizartinib dihydrochloride

    Sponsor: DAIICHI SANKYO INC. Form: TABLET. Route: ORAL

    full page →quizartinib dihydrochloride →fda approvals ↗
    ›Apr 13, 2026approval121d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 13, 2026approval121d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 13, 2026approval121d agoLURASIDONE HYDROCHLORIDE — FDA approvalLURASIDONE HYDROCHLORIDE

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →LURASIDONE HYDROCHLORIDE →fda approvals ↗
    $RDY12.15-0.57%
    $RDHL0.7390+6.64%
    $PYPD4.7700-1.45%
    $AMRX17.88-1.43%
    $NBIX164.92+0.92%
    $PYPD4.7700-1.45%
    $PFE27.05+1.08%
    $PYPD4.7700-1.45%
    $SCNX0.3314-4.08%
    $PYPD4.7700-1.45%
    $AMRX17.88-1.43%